New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q4 2017 call → NOWe need answer YES/NO based on transcript. Need determine if management indicates economic terms of newest business have stepped up meaningfully above company's own recent norm, and improvement only begun to flow into reported results because most reported numbers still older terms. We need parse transcript. Company Pacira, EXPAREL sales. Questions about guidance, J&J partnership, CMS reimbursement, pricing? Need see if management describes new business terms improving vs own recent past, and reported results still old terms. The question asks "ECONOMIC TERMS OF THE COMPANY'S NEWEST BUSINESS — the prices, rates, fees, spreads, contract sizes, durations, or profitability at which its most recent deals, orders, contracts, renewals, or transactions are being struck — have stepped up MEANINGFULLY ABOVE THE COMPANY'S OWN RECENT NORM, and that this improvement in the terms of incoming business has only BEGUN to flow into the reported results, because most of the business in the reported numbers was still written at the older, less favorable terms?" Need look for management words. They discuss guidance conservative, growth initiatives, J&J partnership, CMS reimbursement. But "economic terms" of business? Maybe pricing? EXPAREL price? No mention of price increases. They discuss reimbursement codes, CMS bundling, commercial payers. Could be "separate reimbursement" would create significant opportunity, but not yet achieved. They say "we are working with CMS to have EXPAREL unbundled" and "if we are granted a code" etc. That's future, not achieved. Also "commercial payers already recognize economic advantage of reimbursing EXPAREL separately under C9290" but that's existing? They mention "Securing separate reimbursement for EXPAREL would create a significant opportunity" - future. Not about terms of new business already achieved. Also guidance: "we are guiding to total EXPAREL net product sales of between $300 million and $310 million in 2018. This range aligns with our 2017 year-over-year average daily growth rates recorded during each quarter, ranging from 6% to 10%." They say "While we are very confident in the growth initiatives that are now in place, especially the investment of our partner J&J is making in EXPAREL, projecting the timing of when each of these items will translate into accelerated growth is difficult to predict with certainty.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...